Cronos Group Inc. (CRON) Form 8-K — May 11, 2026
Cronos Group reported its first quarter 2026 results, achieving record net revenue of $45.2 million, a 40% increase year-over-year, driven by higher cannabis flower sales in Israel and other international markets. Net income rose 103% to $15.7 million, while Adjusted EBITDA improved 122% to $5.1 million, bolstered by higher average sales prices and gross profit. The Board of Directors authorized a new share repurchase program for up to $50 million, succeeding the prior program upon its expiration on May 13, 2026. The program allows for repurchases through open market or privately negotiated transactions and is set to run until May 13, 2027, unless terminated earlier.
Key figures
- Eps
- $0.04
- Revenue
- $45.2 million
- Net Income
- $15.7 million
- Revenue Yoy
- 40%
- Cash Position
- $821.856 million
- Adjusted EBITDA
- $5.079 million
- Share Repurchase Amount
- $50 million
Price after filing
Close on the filing date to close N calendar days later (from $2.75). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.